m-PEG8-DSPE - ≥95%

Cat. No.: M595508
DISPONIBLE À COMMANDE
QUALITÉ & PURETÉ ≥95%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
Application
228,229
★
Taille
Allemagne (EU)
USA*
Prix
Qté
25mg
M595508-25mg
Sur commande · 8–12 semaines
875,46€
100mg
M595508-100mg
Sur commande · 8–12 semaines
1 422,14€
Enter a quantity for the sizes you want to add.

Vue d’ensemble

m-PEG8-DSPE is a PEG derivative with a DSPE moiety. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The hydrophilic PEG linker increases the water solubility of the overall compound allowing for the delivery of the drug. Longer PEG chains allows for better water solubility properties compared to shorter PEG chains.

Spécifications

Spécifications et pureté
≥95%
Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Pureté
≥95%

Données avancées

Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculateurs de solution
Avis

Avis des clients

Application Protocols

No item-specific, validated protocols are provided in the product data. Below are general, literature-informed workflows for common uses. Adjust parameters to your system.

  • Liposome with m-PEG8-DSPE (5 mol%) by thin-film hydration

    1. Dissolve phospholipids/cholesterol and m-PEG8-DSPE in CHCl3 (optional: 5–10% MeOH). 2) Evaporate to a thin film. 3) Dry under high vacuum ≥2 h. 4) Hydrate with preheated buffer (e.g., 60–70 °C) while vortexing 30 min. 5) Extrude through 200→100→80 nm membranes at elevated temperature. 6) Dialyze to remove residual solvent.
  • Ethanol injection micelles

    1. Prepare 20 mg/mL ethanolic solution of m-PEG8-DSPE (and cargo if compatible). 2) Inject into warm buffer under vigorous stirring to desired final concentration. 3) Remove ethanol by dialysis/UF. 4) Characterize by DLS and cargo assay.
  • Polymer nanoparticle stabilization

    1. Dissolve hydrophobic polymer in acetone/ethanol. 2) Add to warm aqueous phase containing m-PEG8-DSPE above CMC with rapid mixing. 3) Remove organic solvent; concentrate and filter.

Note: Parameters are general literature guidance and may require optimization. For sterile applications, filter through 0.22 µm at elevated temperature.

Biological Roles

This product is a synthetic PEG–phospholipid designed for research formulations. While not a native biomolecule, its components map onto well-understood biochemical roles.

  • Phospholipid bilayers (context): DSPE is a saturated glycerophospholipid analog; saturated C18 chains elevate bilayer order and transition temperature, imparting rigidity and low permeability in model membranes (literature).
  • PEG corona effects: surface-grafted PEG establishes a hydration layer via excluded volume and entropic repulsion, reducing protein adsorption and colloidal aggregation in complex media (steric stabilization; literature). The m-PEG8 length provides a relatively short brush, enabling closer packing and potentially less curvature stress compared to longer PEGs.
  • Membrane interactions: PEG–DSPE partitions into bilayers with the DSPE anchor in the hydrophobic core and PEG extending to the aqueous phase, modulating interactions with proteins, cells, and extracellular matrices in in vitro systems (research use only).
  • Cargo solubilization: in micellar or vesicular forms, hydrophobic domains can incorporate lipophilic probes/dyes; PEG shell influences circulation in model systems and can limit nonspecific uptake in cell culture experiments (literature, non-clinical).

Note: No medical or clinical claims are made. All discussion pertains to in vitro and preclinical research contexts only.

Buffer Applications

m-PEG8-DSPE is not a pH buffer. However, its assembly and performance depend on the aqueous medium used for hydration and dispersion.

  • Practical guidance (literature-informed)
    • Hydration media: commonly phosphate-buffered saline (PBS), HEPES, or Tris buffers (pH 7.0–7.5) preheated above the lipid’s transition temperature to promote rapid bilayer formation.
    • Ionic strength: moderate salt (e.g., 100–150 mM) screens electrostatics and supports robust vesicle formation; very high ionic strength can alter CMC and size distributions.
    • Additives: small amounts of ethanol (5–20% v/v) or glycerol may facilitate difficult hydrations; remove cosolvents after assembly by dialysis or ultrafiltration.
    • Filtration/extrusion: use 0.22 µm sterile filters or track-etched membranes (50–200 nm) at elevated temperature to achieve monodisperse populations.

No defined buffering capacity or pKa data are applicable to this material; select buffers based on compatibility with co-formulated components and intended biological assays.

Green Alternatives

m-PEG8-DSPE use often involves organic solvents; greener choices and process adjustments can reduce environmental and safety impacts without compromising performance.

  • Greener solvent/process substitutions (literature-informed)

    • Replace chloroform/DCM with ethanol or isopropanol where solubility permits (ethanol injection, solvent-switch, or lyophilization from tert-butanol/water).
    • Minimize solvent volumes by concentrating feed solutions and using microfluidic mixing to enhance nucleation and size control.
    • Employ supercritical CO2-assisted methods or detergent-free film hydration when compatible with cargo and scale.
  • Comparative considerations (informational)

    Solvent/process | Advantages | Trade-offs -|-|- Ethanol injection | Greener, GMP-friendly, easy solvent removal | May require higher temperature for complete dissolution; residual EtOH control needed tert-Butanol freeze-dry | Water-miscible, facile lyophilization | Requires freeze-dryer; solubility of co-lipids must be verified Microfluidic mixing | Low solvent, precise size control | Equipment cost; parameter optimization needed Chloroform film casting | Excellent solubility, co-dissolution of diverse lipids | Toxicity, waste disposal, residual solvent risk

  • Material choice levers

    • Short PEG (PEG8) reduces polymer mass and potential persistence vs long PEG chains; however, shorter PEG may offer less steric stabilization—optimize mole% accordingly.
    • Fully saturated DSPE minimizes oxidative waste streams associated with peroxidation of unsaturated lipids.
Pharmaceutical Uses

No pharmacopeial grade or compendial status is specified for this item. Content below is general formulation context for research and development; no therapeutic or clinical claims are made.

  • Role in formulations (informational)

    • Excipient function: PEG–DSPE lipids serve as steric stabilizers in liposomal and micellar systems, modulating colloidal stability, surface hydration, and opsonization in in vitro evaluations.
    • Process compatibility: ethanol injection, thin-film hydration, and microfluidic mixing are commonly explored in preformulation studies due to their scalability and solvent removal pathways.
    • Tuning PEG density: short PEG chains (PEG8) can be used at adjusted mole% to achieve desired surface properties while limiting polymer mass.
  • Documentation and controls

    • For any translational application, verify residual solvent limits, heavy metals, and bioburden/ endotoxin according to internal specifications; this listing does not provide such grades or limits.
    • Lot-specific CoA review is essential to confirm identity and purity suitable for the intended research use.
  • Grade/purity statement for this item: Not specified for this item; refer to CoA/Spec Sheet.

Physical Properties

Item-specific numeric specifications (MP, BP, density, RI, logP, solubility limits) are not provided in the product data.

  • Item-specific values

    • Melting/phase transition (Tm): Not specified for this item; refer to CoA/Spec Sheet.
    • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • Typical/literature characteristics for mPEG–DSPE amphiphiles (informational)

    • Physical form: waxy solid to glassy solid; forms clear to opalescent solutions in organic solvents; disperses into micelles or bilayers in water upon heating/sonication.
    • Thermal behavior: PEGylated DSPEs commonly exhibit gel–liquid crystalline transitions in the ~55–75 °C range depending on PEG length and hydration (literature). Shorter PEG (e.g., PEG8) tends to retain a relatively high transition temperature due to DSPE’s saturated C18 tails.
    • Solubility profile (qualitative, literature): soluble in chloroform, dichloromethane, and mixtures of chloroform/methanol; soluble in hot ethanol or isopropanol; soluble in DMSO; forms colloidal solutions in aqueous buffers above the critical aggregation concentration (CAC/CMC).
    • Aggregation: assembles into micelles/vesicles; CMC for PEG–DSPEs often falls in the low µM range and depends strongly on PEG length, ionic strength, and temperature (literature; not item-specific).
    • Hygroscopicity: PEG segment is hygroscopic; materials may absorb moisture from air (general note).
Quality and Grades
  • Grade/purity for this specific item: Not specified for this item; refer to CoA/Spec Sheet.

  • General quality considerations for PEG–DSPE materials (informational)

    • Identity & purity assessment: typically confirmed by 1H/13C NMR (lipid and PEG resonances), MALDI-TOF/ESI-MS (polymer distribution centered at target degree of polymerization), and HPLC/UPLC (RP or GPC) to assess lipidic and polymeric impurities.
    • Residual solvent and water: determination by GC/HS-GC and Karl Fischer, respectively; especially important for reproducible film formation and accurate dosing.
    • Acid value/peroxide value: while fully saturated DSPE is oxidation-resistant compared to unsaturated lipids, monitoring peroxide/acid indices supports long-term stability assessments (literature practice; not item-specific).
    • PEG polydispersity: m-PEG8 refers to an average of 8 EO units; narrow dispersity improves batch-to-batch behavior in self-assembly and pharmacotechnical studies.
    • End-group verification: methoxy-termination confirmed by NMR (singlet ~3.3 ppm) and MS; linkage to DSPE (commonly amide) verified by carbonyl signals and MS mass shift.
  • Stabilizers: Not specified for this item; refer to CoA/Spec Sheet.

  • Documentation: A Certificate of Analysis (CoA) typically includes assay, identity, moisture, and chromatographic purity; request the CoA for your lot to verify acceptance criteria.

Reaction and Applications

This product is primarily a self-assembling amphiphile rather than a small-molecule reagent for bond-forming reactions. Its core value lies in colloidal assembly and interfacial engineering.

  • Assembly and formulation (literature examples)

    • Liposomes and stealth coatings: incorporation of m-PEG–DSPE into phospholipid bilayers yields steric stabilization (PEG corona), reducing aggregation and protein adsorption in biological media. PEG8 provides a short brush suitable for tuning surface hydration and inter-lamellar spacing.
    • Micelles and mixed micelles: forms nanoscale micelles capable of solubilizing hydrophobic cargos; co-formulation with other surfactants or lipids modulates size and CMC.
    • Nanoparticle surface modification: anchors to hydrophobic surfaces (e.g., polymer nanoparticles, oil droplets) providing PEGylated shells to enhance colloidal stability and reduce nonspecific interactions.
    • Supported bilayers and coatings: aids in preparing PEGylated supported lipid bilayers and antifouling coatings on inorganic or polymeric substrates.
  • Practical tips

    • Work above the lipid phase transition during hydration (literature: typically 55–75 °C for DSPE-based lipids), using preheated buffers and equipment.
    • Control PEG mole% in bilayers (often 1–10 mol% in literature) to balance colloidal stability with membrane integrity; higher PEG content may increase curvature stress and permeability.
    • Remove organic solvents thoroughly (rotary evaporation + high vacuum) to minimize defects in the assembled structures.
    • Size control by extrusion through polycarbonate membranes or by probe sonication with ice-bath cooling intervals.
Reaction Conditions

As a self-assembling amphiphile, “reaction conditions” map to assembly conditions. The following parameters are general literature guidance and not item-specific specifications.

  • Thin-film hydration

    • Dissolve lipid components in chloroform or CHCl3/MeOH; rotary evaporate to a uniform film; dry under high vacuum ≥2 h.
    • Hydrate with preheated buffer (commonly 60–70 °C for DSPE-based systems) while vortexing/agitating for 15–60 min.
    • Optional: cycle freeze–thaw (5–10 cycles) to enhance lamellarity equilibration; size by extrusion (50–200 nm membranes) at elevated temperature.
  • Ethanol injection / solvent switch

    • Prepare a concentrated ethanolic solution (e.g., 10–50 mg/mL); inject into vigorously stirred, preheated buffer (lipid final 0.5–10 mg/mL).
    • Remove ethanol by dialysis, diafiltration, or rotary evaporation under reduced pressure.
  • Sonication and sizing

    • Probe sonication in pulse mode with cooling intervals can yield small unilamellar vesicles; avoid overheating by monitoring temperature.
  • Micelle preparation

    • Dissolve in DMSO or ethanol; dilute into warm buffer to target concentration above the CMC; remove cosolvent as needed.
  • Quality controls

    • Measure size/PDI by DLS; check encapsulation by UV/fluorescence or HPLC; assess stability over time via size, turbidity, and leakage assays.
Safety and Handling
  • GHS classification, pictograms, and H-statements: Not specified for this item; consult the SDS for authoritative safety information.
  • General hazards (class-based, informational): PEGylated saturated phospholipids are generally considered low volatility, low acute hazard laboratory materials. Avoid inhalation of dust/aerosols and contact with eyes/skin.
  • Personal protective equipment (PPE): laboratory coat, safety glasses, and appropriate gloves (e.g., nitrile). Handle powders/films in a fume hood to minimize aerosolization.
  • Handling notes
    • Avoid prolonged exposure to elevated temperatures; heat only as needed to exceed the lipid’s phase transition during hydration or processing.
    • Prevent moisture ingress during storage; PEG segments are hygroscopic and films may retain water affecting weigh-outs and reproducibility.
    • Although DSPE is fully saturated (low oxidative liability), standard good practice is to limit exposure to air and light; use inert gas blanket when preparing thin films.
  • Incompatibilities (general): strong oxidizers; strong acids/bases that may hydrolyze ester linkages on prolonged contact; halogenating agents.
  • First aid (summary; see SDS): rinse eyes/skin with water for several minutes if contacted; remove contaminated clothing; if inhaled, move to fresh air; if ingested, rinse mouth and seek medical advice. Provide SDS to medical personnel.
  • Spill/cleanup: collect solids with minimal dust generation; for solutions, absorb with inert material. Dispose according to local regulations.
Solvent Selection

As an amphiphilic PEG–phospholipid, m-PEG8-DSPE dissolves well in certain organic solvents and self-assembles in water. Choose solvents based on process (film casting, ethanol injection, micellization, or membrane extrusion).

  • Qualitative miscibility/solubility (literature guidance)

    • Good solvents: chloroform, dichloromethane, chloroform/methanol (2:1 to 9:1), DMSO, hot ethanol or isopropanol.
    • Limited aqueous solubility as monomers; forms micelles/vesicles upon hydration above Tm with agitation/sonication.
    • Mixed co-solvent approaches (e.g., ethanol or tert-butanol with water) facilitate rapid injection or lyophilization.
  • Selection tips

    • Thin-film hydration: dissolve the lipid(s) in chloroform or CHCl3/MeOH, rotary evaporate to a uniform film, dry under vacuum, then hydrate with preheated buffer above the lipid’s transition temperature.
    • Ethanol injection: prepare a concentrated ethanolic solution and inject into heated aqueous buffer under stirring; residual ethanol is removed post-assembly by dialysis or diafiltration.
    • Avoid strong polar aprotic bases or concentrated acids that may hydrolyze ester bonds upon prolonged contact.
  • Comparison (informational)

    • Ethanol vs chloroform: ethanol is greener and compatible with pharmaceutical process streams; chloroform offers excellent solubility for co-dissolving many lipids and hydrophobes but entails higher toxicity and disposal burdens.
Storage and Reconstitution
  • Storage (item-specific)

    • Store at -20 °C (per product data). Keep tightly closed, desiccated, and protected from light. Minimize freeze–thaw and headspace moisture.
    • Shipped in: Ice chest + ice pads (per product data). Inspect upon receipt; allow to equilibrate in a desiccator before opening.
  • Reconstitution and handling (general guidance)

    • For stock solutions: dissolve the required amount in chloroform (or CHCl3/MeOH) for film casting, or in ethanol/DMSO for solvent-switch methods. Prepare solutions freshly when possible.
    • For films: after solvent removal, dry under high vacuum to constant mass. Store films under inert gas at -20 °C.
    • Hydration: use preheated buffer above the lipid’s phase transition; vortex/sonicate to aid dispersion. Extrude or sonicate to target size.
    • Aqueous storage: short-term at 2–8 °C; for longer-term, freeze formulated dispersions at -80 °C or lyophilize with suitable cryo/lyoprotectants when compatible. Avoid repeated freeze–thaw cycles.
  • Stability notes

    • Although DSPE is saturated, limit exposure to oxygen and light during processing. Use amber glassware and inert atmosphere when feasible.
    • Item-specific shelf life or stability data: Not specified for this item; refer to CoA/Spec Sheet.
  • Research use only (per product data).

Structure and Identity

m-PEG8-DSPE is a PEGylated phospholipid comprising a distearoyl phosphoethanolamine (DSPE) hydrophobic anchor covalently linked to a short, methoxy-terminated polyethylene glycol chain of 8 ethylene glycol repeat units (m-PEG8).

  • Item-specific identifiers

    • CAS: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES / InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (general/literature description)

    • Lipid tail domain: two saturated C18 stearoyl chains esterified to glycerol at sn-1 and sn-2 (DSPE core), furnishing a strong hydrophobic anchor with a high gel–liquid crystalline transition temperature.
    • Polar headgroup: phosphoethanolamine at sn-3, further derivatized through the ethanolamine nitrogen to an amide (or equivalent stable linkage) bearing m-PEG8, terminating in a methoxy cap (–OCH3).
    • Amphiphile architecture: AB-type with bulky hydrophilic PEG corona and compact, saturated twin-tail hydrophobe; self-assembles into micelles, vesicles, and stabilizes liposome coronas.
    • Stereochemistry: native glycerol backbone is prochiral; commercial DSPE materials are typically racemic at the sn-center unless specified (literature note).
Synthetic Utility

While not a classical small-molecule building block, m-PEG8-DSPE is a versatile surface-active construct for assembling functional nanostructures and interfaces.

  • Functional group and architecture leverage

    • Hydrophobic DSPE twin tails enable strong insertion into bilayers and adsorption onto hydrophobic polymer or inorganic surfaces.
    • The methoxy-terminated PEG8 imparts a neutral, protein-resistant corona; although end-capped (nonreactive), it can serve as a diluent or spacer when blended with reactive PEG–lipids (e.g., maleimide-PEG–DSPE) to control ligand density.
  • Typical synthetic/formulation roles (literature)

    • Co-formulant in liposomes to adjust steric stabilization and circulation-mimicking properties in vitro.
    • Stabilizer for nanoprecipitation of hydrophobic polymers (e.g., PLGA) by providing a PEG shell via hydrophobic anchoring of DSPE.
    • Component of mixed micelles for solubilizing membrane proteins or hydrophobic dyes in analytical workflows.
    • Additive in supported lipid bilayer preparation to modulate antifouling behavior and reduce nonspecific adsorption in biosensing.
  • Retrosynthetic perspective

    • The molecule can be viewed as DSPE–(amide)–PEG8–OMe. Though the PEG terminus is nonreactive, blending strategies with reactive PEG–lipids allows modular display of ligands while maintaining colloidal stability.
Target Specificity

Not applicable. This product is a PEGylated phospholipid excipient, not a biological targeting reagent or antibody. No antigen/epitope specificity, clone, or isotype data apply.

Foire aux questions

What is the purity of this product?
This product is supplied at ≥95% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.